BRIDGEWATER, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go^® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for people with diabetes, today announced it is proudly partnering with the AADE on their Diabetes Advanced Network Access (DANA) technology resource website, DANAtech.org.

DANA was launched in 2018 by the AADE as a source for healthcare professionals to keep up with technology options for people with diabetes, prediabetes and other cardio metabolic conditions. With new technologies hitting the market every year, DANA gives users a central resource to learn about diabetes device options and technology resources that can meaningfully enhance positive outcomes for their patients. As part of the Company’s partnership with the AADE as a sponsor of its DANA site, V-Go product information and clinical data will be included within the product section of DANA.

“We have long been strong advocates for AADE and the great work they have done in improving care for people with diabetes,” said John Timberlake, President and Chief Executive Officer of Valeritas. “We believe the development of a centralized “one-stop” diabetes resource is a fantastic idea, and we are thrilled to be a part of it.”

About Valeritas Holdings, Inc.

Valeritas is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas’ flagship product, V-Go^® Wearable Insulin Delivery device, is a simple, affordable, all-in-one basal-bolus insulin delivery option for patients with type 2 diabetes that is worn like a patch and can eliminate the need for taking multiple daily shots. V-Go administers a continuous preset basal rate of insulin over 24 hours, and it provides discreet on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in Marlborough, Massachusetts.

More information is available at www.valeritas.com and our Twitter feed @Valeritas_US, www.twitter.com/Valeritas_US.

About AADE

AADE is an inter-disciplinary professional membership organization dedicated to improving prediabetes, diabetes and cardiometabolic care through innovative education, management and support. With more than 14,000 professional members including nurses, dietitians, pharmacists, exercise specialists, and others, AADE has a vast network of practitioners working with people who have, are affected by or are at risk for diabetes. Learn more at www.diabeteseducator.org, or visit us on Facebook (American Association of Diabetes Educators), Twitter (@AADEdiabetes) and Instagram (@AADEdiabetes).